IRVINE, California and LONDON, December 11 /PRNewswire/ --

- New Americas Partner Displaces AppStream with Endeavors AppExpress

Endeavors Technologies, the pioneer in application streaming and virtualization technology, and its parent company, Tadpole Technology plc, today announced a partner agreement with Vector Networks, a leading provider of desktop management software for the enterprise. Vector is integrating Endeavors' application streaming and virtualization software as a key component of its IT Asset Management Solution.

CHESHIRE, Connecticut, December 11 /PRNewswire/ --

- Data Presented at the American Society of Hematology (ASH) Annual Meeting

- Publication Number: 840

Soliris(R) (eculizumab) therapy reduced hemolysis, fatigue, thromboses (blood clots) and transfusion requirements in patients with a rare blood disorder called paroxysmal nocturnal hemoglobinuria (PNH), including those who might have been expected to have less severe disease, according to data from an ongoing open-label clinical study presented today at the 49th Annual Meeting of the American Society of Hematology Meeting in Atlanta.

BASEL, Switzerland, December 11 /PRNewswire/ --

- Higher Response Rates Seen in Untreated and Relapsed CLL Patients

For non-US media only

Abstract Number: 626

Abstract Number: 752

Early results from two phase II trials tracking the outcome of patients with chronic lymphocytic leukaemia (CLL) who were treated with the innovative cancer therapy MabThera (rituximab) have revealed very promising results. The study outcomes, presented at the 49th Annual Meeting of the American Society of Hematology in Atlanta, come from the first prospective trials demonstrating the efficacy of MabThera in CLL patients and highlight the impact MabThera is having on CLL, a disease in which there has not been a significant treatment advance in nearly a decade.

JERUSALEM, Israel, December 11 /PRNewswire/ --

- DS Vision 3000 Now Reaches 600m

Minicom Advanced Systems is proud to announce the extended range of its DS Vision 3000. The CATx based distribution system which delivers HD video and stereo-audio content from a player to multiple screens has doubled its scope from 300m (1000ft) to 600m (2000ft).

According to Eran Kessel, Vice President for Marketing at Minicom, "The increased range of the DS Vision 3000 makes it an even more powerful solution to any digital signage solution. To be able to send high quality images over this distance and price-performance is something that no-one else has been able to achieve."

SAN MATEO, California, December 11 /PRNewswire/ --

- Seeks UK partners to target new vertical and geographic markets

We are advised by dotMobi that journalists and other readers should disregard the news release, "Third .mobi 'Premium Domain Name' Online Auction Shatters Existing Price Records," issued December 10th over PR Newswire, as the release was issued prematurely.

Vance Hedderel of dotMobi, +1-703-485-5563, vhedderel@mtld.mobi; or Danielle Siemon of A&R Edelman for dotMobi (US), +1-650-762-2947, danielle.siemon@edelman.com; or Sasha Manners of Edelman for dotMobi (Europe), +44-20-7344-1504, sasha.manners@edelman.com; or Kate Donahue of Sedo, Director of Marketing, +1-617-499-7260, kate@sedo.com

PITTSBURGH, December 11 /PRNewswire/ --

Panopto, Inc. announced today that its CourseCast lecture-capture technology-developed and first implemented at Carnegie Mellon University-is being made available to qualified academic institutions free of charge.

CourseCast's easy-to-deploy lecture-capture technology enables educators to capture, edit, index, archive and stream video and audio over the Internet. CourseCast gives students on-demand access to indexed lectures and course material, enabling them to experience or revisit entire lectures, or to focus on segments of their choice. CourseCast is easily deployed using standard PCs and peripherals, which substantially drives down the cost of lecture-capture deployment.

LONDON, December 11 /PRNewswire/ --

- There's 15,000 Holiday Euros for the European Quitter!

The search is on for the first European Smoke Free Quitter of the Year 2008 who will be awarded the title and holiday vouchers worth 15,000 Euros. Eleven countries are participating including the UK and they will all choose a representative who will win a trip to the Award ceremony in Amsterdam in September 2008. You can also nominate a health care professional that has helped smokers quit and a public figure that has made an impact on smoking policy. To enter or nominate apply on line at http://www.quit.org.uk or ring Quitline 0800 002200

CALGARY, Canada, December 11 /PRNewswire/ -- Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ("Oncolytics") today announced that it has been granted U.S. Patent 7,306,902 entitled "Oncolytic Viruses as Phenotyping Agents for Neoplasms." The claims describe methods of diagnosing cancers with unknown phenotypes by using oncolytic viruses that selectively replicate in cancer cells with known phenotypes.

"Oncolytic viruses are selective for certain mutations in cancer cells," said Dr. Matt Coffey, Chief Scientific Officer of Oncolytics. "By using these viruses in tumour samples, we may be able to more accurately diagnose the various cancer phenotypes, ultimately leading to a more individualized approach to cancer treatment."

About Oncolytics Biotech Inc.

A team of astronomers have used the NASA/ESA Hubble Space Telescope to detect, for the first time, strong evidence of hazes in the atmosphere of a planet orbiting a distant star. The discovery comes after extensive observations made recently with Hubble’s Advanced Camera for Surveys (ACS).

The team, led by Frédéric Pont from the Geneva University Observatory in Switzerland, used Hubble’s ACS to make the first detection of hazes in the atmosphere of the giant planet. "One of the long-term goals of studying extrasolar planets is to measure the atmosphere of an Earth-like planet, this present result is a step in this direction" says Pont.